1 January 2019 in Journal of Neuroimmunology
16 June 2021 in Clinical and Experimental Pharmacology and Physiology
23 June 2025 in Reproductive Sciences
Alchemilla vulgaris has traditionally been used to treat gynecologic diseases. The anti-inflammatory and vasorelaxant effects of the extract of A. vulgaris (AVE) have been reported in previous studies. This study aimed to investigate the effects of A. vulgaris on PCOS, one of the most common metabolic disorders in adult women of reproductive age, accompanied by inflammation and vascular endothelial dysfunction, in an experimental animal model. Three groups of prepubertal female Wistar rats were established: PCOS, Control, and PCOS + AVE groups. Subcutaneous dehydroepiandrosterone (DHEA) was administered for 35 days to the PCOS and PCOS + AVE groups. The rats in the PCOS + AVE group were orally administered AVE (50 mg/100 g bw/day) for 35 days. Systemic blood pressure, vascular endothelial function, ovarian morphology, and endocrine biomarker levels were measured at the end of the experiment. TNF-α levels were also evaluated in the thoracic aorta and ovaries. Hormonal imbalances, ovarian morphological changes, and endothelial dysfunction were observed in the PCOS group, which returned to the controls after AVE treatment. Furthermore, AVE attenuated the aortic and ovarian levels of TNF-α in the PCOS group. Our study suggests that AVE may have beneficial effects in the treatment of PCOS due to its anti-inflammatory and vasculoprotective properties. Graphical Abstract
12 December 2018 in TURKISH JOURNAL OF MEDICAL SCIENCES
Background/aim: Epileptic seizure leads to sudden unexpected death in epilepsy (SUDEP) among affected patients. The causes of SUDEP are still unclear. The aim of this study was to research the effect of epilepsy on myocardial injury and arrhythmias during experimentally induced acute myocardial ischemia. Materials and methods: Wistar albino rats were divided into four groups: sham, pentylentetrazole (PTZ) + sham, ischemia, and PT% + ischemia groups. PTZ (65 mg/kg, ip) was given 2 h before ischemia. Seizure scoring was conducted by evaluating the PTZ-induced behavioral changes in the rats. The left main coronary artery was ligated in anesthetized rats for 30 min. The incidence and the number of ventricular arrhythmias were determined. Histopathological scoring was performed for tissue injury by using a microscope. Results: Seizure scores were not different among the groups (P > 0.05). The incidence and number of ventricular tachycardia (VT) episodes were significantly higher in the PTZ + ischemia group than in the ischemia group (P < 0.05). More prominent myocardial damage was observed in the PTZ + ischemia group than in the other groups (histopathological scores: PTZ + ischemia; 2.5 +/- 0.5 versus ischemia; 1.2 + 0.4, P < 0.05). Conclusion: PTZ-induced seizure in rats increased myocardial injury and the incidence and number of VT episodes in myocardial ischemia. These results reveal that seizure in epilepsy patients may increase ventricular arrhythmia and myocardial injury during heart attack.
17 March 2026 in Istanbul University Journal of Health Sciences Research
Objective: This study aimed to evaluate the effects of chronic low-dose mercury exposure during gestation and lactation on the pancreatic endocrine architecture and function in epileptic WAG/Rij rats, elucidating the potential link between developmental toxicant exposure and later metabolic-neural comorbidity.Materials and Methods: Pregnant WAG/Rij rats received intramuscular injections of mercuric chloride (initial dose, 4.6 μg/kg; maintenance dose, 0.07 μg/kg/day) throughout gestation and lactation. The offspring were assessed at postnatal month 5. Body weight and fasting blood glucose were measured. Pancreatic tissues were harvested for histopathological assessment, immunohistochemistry (insulin, glucagon, somatostatin), and Western blotting for quantitative protein expression. Statistical analyses were performed using the Student’s t-test (GraphPad Prism 9.0).Results: Mercury-exposed offspring exhibited significantly elevated body weight (p<0.05) and fasting blood glucose levels (p<0.0001) relative to controls. Immunohistochemical analysis revealed a marked reduction in insulin-positive increase in the numbers of glucagon- and somatostatin-positive cells within the islets. Western blot data confirmed decreased β-actin-normalised insulin expression alongside increased glucagon and somatostatin protein levels. These results indicate pronounced endocrine disruption and β-cell dysfunction following exposure to mercury during the perinatal period.Conclusion: Chronic developmental exposure to low-dose mercury profoundly disrupts pancreatic endocrine homeostasis in epileptic rats, characterized by β-cell depletion and systemic hyperglycemia. These findings support the developmental origins of the health and disease framework and address that early-life mercury exposure may predispose patients to long-term metabolic and neurological comorbidities. Further investigations should focus on the molecular mechanisms, particularly oxidative stress, mitochondrial dysfunction, and the perturbation of calcium signalling, that mediate mercury-induced cell injury.